A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hanmi Pharmaceutical Company Limited
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 19
Patients who understood the contents and purpose of this trial and signed informed consent form
Patients with essential hypertension and dyslipidemia
You may not be if
Patients with differences between arms greater than 20 mmHg for mean sitSBP or 10 mmHg for mean sitDBP
Patients with mean sitSBP ≥ 180 mmHg or mean sitDBP ≥ 110 mmHg
Concomitant administration of cyclosporine
Tolerance or Hypersensitivity Angiotensin II receptor blocker or HMG-CoA reductase inhibitor, Calcium channel blocker(dihydropyridine) or Multi-drug allergy
Hereditary angioedema or medical history of angioedema in the treatment of ACE inhibitors or angiotensin II receptor blockers
Fibromyalgia, myopathy, rhabdomyolysis or acute myopathy or medical history of adverse effect to statin
CPK normal range \> 2 times
Secondary hypertension and suspected secondary hypertension
Orthostatic hypotension with symptoms
Uncontrolled primary hypothyroidism(TSH normal range ≥ 1.5 times)
Severe hepatopathy or active hepatopathy (AST or ALT normal range ≥ 3 times)
Active gout or hyperuricemia(uric acid ≥ 9mg/dL)
IDDM or uncontrolled type 2 diabetes mellitus (HbA1c \> 9%)
Ventricular arrhythmia
Medical history
* Severe heart disease(heart failure of NYHA class III-IV)
* Severe cerebrovascular disease within 6 months (cerebral infarction, cerebral hemorrhage), hypertensive encephalopathy, transient cerebral ischemic attack(TIA)
* Hypertrophic obstructive cardiomyopathy, severe obstructive coronary artery disease, aortic stenosis, hemodynamically significant stenosis in aortic valve or mitral valve
* Ischemic heart disease(myocardial infarction, angina) within 6months
* Angioplasty or coronary artery bypass graft(CABG) surgery within 6months